Aeterna zentaris yahoo finance
Aug 21, 2019 · CHARLESTON, S.C., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. () today announced that Jonathan Pollack has resigned as a director of the Company for personal reasons, effective immediately. The board of directors of the Company has appointed Carolyn Egbert, existing director and Chairperson, to replace Mr. Pollack on the audit committee. Aeterna Zentaris: 4Q Earnings Snapshot - Yahoo Mar 26, 2019 · SUMMERVILLE, S.C. (AP) _ Aeterna Zentaris Inc. (AEZS) on Tuesday reported a loss of $5.1 million in its fourth quarter. The Summerville, South Carolina-based company said it had a loss of 31 cents per share. The drug developer posted revenue of $1.4 million in the period. AEterna Zentaris Inc. AEZS Message Board - Investors Hangout AEZS Stock Message Board for Investors. AEterna Zentaris Inc. Stock Price, News and Company Updates. Message Board Total Posts: 70
Aeterna Zentaris is a specialty biopharmaceutical company with laser-focus on developing and commercializing, principally through out-licensing arrangements, macimorelin, an orally available ghrelin agonist, to be used in the diagnosis of patients with Adult Growth Hormone Deficiency (AGHD).
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used Aeterna Zentaris Inc. (AEZS) Interactive Stock ... - Yahoo Aeterna Zentaris Announces Closing of $4.5 Million Registered Direct Offering Priced At-The-Market. Additionally, the Company issued to the investors unregistered warrants to purchase up to an aggregate of 2,608,696 common shares in a concurrent private placement. Aeterna Zentaris Aeterna Zentaris is a specialty biopharmaceutical company with laser-focus on developing and commercializing, principally through out-licensing arrangements, macimorelin, an orally available ghrelin agonist, to be used in the diagnosis of patients with Adult Growth Hormone Deficiency (AGHD). Aeterna Zentaris Inc. (AEZS) - au.finance.yahoo.com Aeterna Zentaris Announces Closing of $4.5 Million Registered Direct Offering Priced At-The-Market. Additionally, the Company issued to the investors unregistered warrants to purchase up to an aggregate of 2,608,696 common shares in a concurrent private placement.
View the basic AEZS option chain and compare options of Aeterna Zentaris Inc. on Yahoo Finance.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. … AEZS - Aeterna Zentaris Inc. Stock Price, Detailed Quote ... finance.yahoo.com Jan 8, 2020 Companies Like Aeterna Zentaris (TSE:AEZS) Can Be Considered Quite Risky. finance.yahoo.com Dec 30, 2019 Hedge Funds Have Never Been This Bullish On AEterna Zentaris Inc. (AEZS) finance.yahoo.com Dec 21, 2019 Aeterna Zentaris Announces Publication of GHD Management Guidelines. finance.yahoo.com 2012 Preview: Aeterna Zentaris - AOL Finance Jan 02, 2012 · With 2011 in the books, it's time to reflect on what has transpired in the year and what companies could be facing business-altering decisions in 2012. On today's plate we have small-cap AEterna Zentaris Debt to Equity Ratio | AEZS
Aeterna Zentaris Inc - SwingTradeBot Canada
AEterna Zentaris Inc. AEZS Message Board - Investors Hangout AEZS Stock Message Board for Investors. AEterna Zentaris Inc. Stock Price, News and Company Updates. Message Board Total Posts: 70 Aeterna Zentaris jumps on FDA approval, Honda bets ... - Yahoo Dec 21, 2017 · Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold. Yahoo Finance. 21 December 2017. Here’s a look at some of the companies the Yahoo Finance team will be watching for you today. Investors are getting a healthy dose of Aeterna Zentaris today. The biopharma company is up big after the FDA approved AEterna Zentaris Inc. (AEZS): Yahoo Finance ONLY $280 K ... AEterna Zentaris Inc. AEZS Stock Message Board: Yahoo Finance ONLY $280 K REVENUES and 180
AEZS: AEterna Zentaris Inc. - Interactive Chart Chart. Get the latest Interactive Chart for AEterna Zentaris Inc. from Zacks Investment Research
Aeterna Zentaris Inc. (AEZS) stock forum ... - Yahoo Find the latest Aeterna Zentaris Inc. (AEZS) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Aeterna Zentaris Inc. (AEZS) Options Chain - Yahoo Finance View the basic AEZS option chain and compare options of Aeterna Zentaris Inc. on Yahoo Finance. AEZS - Stock quote for AETERNA ZENTARIS INC. - MSN Money
Dec 01, 2019 · AEZS on Yahoo! Finance; Aeterna Zentaris Inc. was founded in 1990 and is headquartered in Quebec City, Canada. Chemistry Biopharmaceutical Cancer Treatment Of Cancer Oncology Solid Tumors Prostate Cancer Lymphoma Peptides Neuroblastoma Glioma Treatment Of Prostate Cancer Gnrh Antagonists Anthracyclines Endometrial Cancer In Vitro Aeterna Zentaris Announces Director Change - Yahoo Aug 21, 2019 · CHARLESTON, S.C., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. () today announced that Jonathan Pollack has resigned as a director of the Company for personal reasons, effective immediately. The board of directors of the Company has appointed Carolyn Egbert, existing director and Chairperson, to replace Mr. Pollack on the audit committee. Aeterna Zentaris: 4Q Earnings Snapshot - Yahoo Mar 26, 2019 · SUMMERVILLE, S.C. (AP) _ Aeterna Zentaris Inc. (AEZS) on Tuesday reported a loss of $5.1 million in its fourth quarter. The Summerville, South Carolina-based company said it had a loss of 31 cents per share. The drug developer posted revenue of $1.4 million in the period. AEterna Zentaris Inc. AEZS Message Board - Investors Hangout AEZS Stock Message Board for Investors. AEterna Zentaris Inc. Stock Price, News and Company Updates. Message Board Total Posts: 70